Spa-1, a negative regulator of Rap1, is expressed following T cell receptor ligation and CD28 costimulation, and is expressed in a subset of rheumatoid arthritis synovial T cells.

被引：0
|
作者：
da Cruz, Tania C. [1 ]
Ariotti, Silvia [1 ]
Abreu, Joana R. [1 ]
Tak, Paul P. [1 ]
Reedquist, Kris A. [1 ]
机构：
[1] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands
来源：
ARTHRITIS AND RHEUMATISM | 2006年 / 54卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S751 / S751
页数：1
相关论文
共 47 条
  • [31] Analysis of PD-1 and Tim-3 expression on CD4+ T cells of patients with rheumatoid arthritis; negative association with DAS28
    Zohreh Koohini
    Hadi Hossein-Nataj
    Maryam Mobini
    Aref Hosseinian-Amiri
    Alireza Rafiei
    Hossein Asgarian-Omran
    Clinical Rheumatology, 2018, 37 : 2063 - 2071
  • [32] Analysis of PD-1 and Tim-3 expression on CD4+ T cells of patients with rheumatoid arthritis; negative association with DAS28
    Koohini, Zohreh
    Hossein-Nataj, Hadi
    Mobini, Maryam
    Hosseinian-Amiri, Aref
    Rafiei, Alireza
    Asgarian-Omran, Hossein
    CLINICAL RHEUMATOLOGY, 2018, 37 (08) : 2063 - 2071
  • [33] Reciprocal Activation of CD4+T Cells and Synovial Fibroblasts by Stromal Cell-Derived Factor 1 Promotes RANKL Expression and Osteoclastogenesis in Rheumatoid Arthritis
    Kim, Hae-Rim
    Kim, Kyoung-Woon
    Kim, Bo-Mi
    Jung, Hong-Geun
    Cho, Mi-La
    Lee, Sang-Heon
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 (03) : 538 - 548
  • [34] CD1c-Expressing Myeloid Dendritic Cells From Joints of Rheumatoid Arthritis Patients Produce Increased Levels of T Cell-Attracting Chemokines and Strongly Activate Autologous T Cells.
    Moret, F. M.
    Hack, C. E.
    Lafeber, F. P. J. G.
    Radstake, T. R. D. J.
    van Roon, J. A. G.
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S459 - S460
  • [35] HLA-DRB1 Shared Epitope Alleles and Disease Activity Are Correlated with Reduced T Cell Receptor Repertoire Diversity in CD4+T Cells in Rheumatoid Arthritis
    Sakurai, Keiichi
    Ishigaki, Kazuyoshi
    Shoda, Hirofumi
    Nagafuchi, Yasuo
    Tsuchida, Yumi
    Sumitomo, Shuji
    Kanda, Hiroko
    Suzuki, Akari
    Kochi, Yuta
    Yamamoto, Kazuhiko
    Fujio, Keishi
    JOURNAL OF RHEUMATOLOGY, 2018, 45 (07) : 905 - 914
  • [36] Deficiency of regulatory CD4+T-cell subset (Tr1) in rheumatoid arthritis: Relationship between Tr1 cells and TH1/TH2 balance.
    Yudoh, K
    Matsuno, H
    Nakazawa, F
    Yonezawa, T
    Katayama, R
    Kimura, T
    ARTHRITIS AND RHEUMATISM, 1999, 42 (09): : S264 - S264
  • [37] CD19-specific CAR T Cells that Express a PD-1/CD28 Chimeric Switch-Receptor are Effective in Patients with PD-L1-positive B-Cell Lymphoma
    Liu, Hui
    Lei, Wen
    Zhang, Chaoting
    Yang, Chunmei
    Wei, Juying
    Guo, Qunyi
    Guo, Xiaojun
    Chen, Zhilu
    Lu, Ying
    Young, Ken H.
    Lu, Zheming
    Qian, Wenbin
    CLINICAL CANCER RESEARCH, 2021, 27 (02) : 473 - 484
  • [38] CD28 costimulation mediates down-regulation of p27kip1 and cell cycle progression by activation of the PI3K/PKB signaling pathway in primary human T cells
    Appleman, LJ
    van Puijenbroek, AAFL
    Shu, KM
    Nadler, LM
    Boussiotis, VA
    JOURNAL OF IMMUNOLOGY, 2002, 168 (06): : 2729 - 2736
  • [39] Cutting Edge: Bispecific gd T Cell Engager Containing Heterodimeric BTN2A1 and BTN3A1 Promotes Targeted Activation of Vg9Vd2+T Cells in the Presence of Costimulation by CD28 or NKG2D
    Lai, Anne Y.
    Patel, Arpita
    Brewer, Faraha
    Evans, Kinsley
    Johannes, Kellsey
    Gonzalez, Louis E.
    Yoo, Kyung Jin
    Fromm, George
    Wilson, Keith
    Schreiber, Taylor H.
    de Silva, Suresh
    JOURNAL OF IMMUNOLOGY, 2022, 209 (08): : 1475 - 1480
  • [40] Parallel comparison of 4-1BB or CD28 co-stimulated CD19-targeted chimeric antigen receptor-T cells for B-cell non-Hodgkin lymphoma
    Ying, Z.
    He, T.
    Wang, X.
    Zheng, W.
    Lin, N.
    Tu, M.
    Xie, Y.
    Ping, L.
    Zhang, C.
    Liu, W.
    Deng, L.
    Qi, F.
    Lu, X.
    Ding, Y.
    Song, Y.
    Zhu, J.
    ANNALS OF ONCOLOGY, 2019, 30 : 482 - 482
12345